A. Roeth - Westdeutsch Tumorzentrum, Univ Klinikum Essen AoR

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 71 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The phase III, randomized, multicenter commodore 2 trial: results from the study of crovalimab vs eculizumab in paroxysmal nocturnal hemoglobinuria (PNH) patients naive to complement inhibitors

A. Roeth, G. He, A. Brodsky,C. Chai-Adisaksopha, T. Dumagay, R. Demichelis Gomez,M. Hoglund,R. J. Kelly, J. -H Lee, J. - Nishimura, N. Obara,A. Risitano,A. Gaya, A. Appius, B. Gentile,R. Negricea, Z. Zhang, S. Buatois, B. Han

ONCOLOGY RESEARCH AND TREATMENT (2023): 294-295

Cited0Views0Bibtex

Intraspinal extramedullary hematopoietic mass (EMH) in a luspatercept-treated patient with transfusion-dependent beta-thalassemia (TDT)

F. Poppenborg,C. Poettgen, C. Moeller-Hartmann, A. Schneider,H. C. Reinhardt,A. Roeth,F. Alashkar

ONCOLOGY RESEARCH AND TREATMENT (2023): 299-300

Cited0Views0Bibtex

The phase III randomized, multicenter commodore 1 trial: comparison of crovalimab vs eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria (PNH)

A. Roeth, P. Scheinberg, D. Villa Cle, J. Edwards,V. Giai,M. Hus, J. S. Kim, C. Barrenetxea Lekue, Z. Nagy,E. Nur,J. Panse, Y. Ueda,M. N. Yenerel, A. Appius, N. Balachandran,S. Chebon, B. Gentile, S. Buatois,A. Kulasekararaj

ONCOLOGY RESEARCH AND TREATMENT (2023): 200-201

Cited0Views0Bibtex

Efficacy and safety of oral therapy with iptacopan compared to standard intravenous therapy with eculizumab or ravulizumab in the treatment of paroxysmal nocturnal hemoglobinuria (PNH): results of the randomized controlled open-label multicenter phase III study APPLY-PNH

A. Roeth,R. Peffault de Latour,A. Kulasekararaj, P. Scheinberg, Y. Ueda,C. de Castro,E. Di Bona,H. Schrezenmeier, S. M. Langemeijer,W. Barcellini,J. Panse,P. Schafhausen, V. A. Mauad,C. Kerloeguen, R. Kumar, C. Thorburn, S. Maitra,M. Dahlke,A. M. Risitano

ONCOLOGY RESEARCH AND TREATMENT (2023): 42-44

Cited0Views0Bibtex

Luspatercept in Patients with transfusion-dependent -Thalassemia: the first real-world Analysis

F. Alashkar, C. P. Lange, R. Yamamoto,H. C. Reinhardt,A. Roeth

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022): 49-49

Cited0Views0Bibtex

Voxelotor in Adolescents and Adults with Sickle Cell Disease: First Experiences from the German Hardship Program

F. Alashkar,A. Roeth,H. C. Reinhardt, C. Franzen, J. Peetz,M. Papathanasiou,D. Reinhardt,S. Halimeh, C. Aramayo-Singelmann

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022): 48-48

Cited0Views0Bibtex

Inhibition of complement C1s by sutimlimab (SUT) in patients with cold agglutinin disease (CAD): results on efficacy and safety from the randomized, placebo-controlled phase 3 CADENZA study (NCT03347422)

A. Roeth,S. Berentsen,W. Barcellini,S. D'Sa,B. Jilma, M. Michel,I. C. Weitz, M. Yamaguchi,J. -i Nishimura,J. M. Vos,M. Storek, N. W. Wong,P. Patel,X. Jiang,D. Vagge,M. Wardecki,F. Shafer,M. Lee,C. M. Broome

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022): 172-173

Cited0Views0Bibtex

Ravulizumab reduces the risk of thrombosis in adult patients with paroxysmal nocturnal hemoglobinuria and high disease activity: 2-year data from a Phase 3, open-label study

A. Roeth,Peffault R. de latour,A. Hill, W. Fuereder,C. Piatek,M. Griffin,M. Ogawa,J. Wang,K. Usuki,J. W. Lee

ONCOLOGY RESEARCH AND TREATMENT（2021）

Cited0Views0Bibtex

Transfusion Requirements In Adult Patients With Paroxysmal Nocturnal Hemoglobinuria With Or Without A History Of Bone Marrow Disorder Receiving Ravulizumab And Eculizumab: Results From A Phase 3 Non-Inferiority Study Extension

A. Risitano,T. Munir,J. Ho Jang,G-W Lee,W. Wanachiwanawin,H. Schrezenmeier,Y. Yonemura,R. Pavani,J. Wang,A. Kulagin,A. Kulasekararaj,F. Sicre De Fontbrune,A. Roeth

BLOOD（2021）

Cited0Views0Bibtex

Ravulizumab reduces thrombosis risk in adult PNH patients: 2-year data

A. Rovo,R. Peffault de Latour,A. Hill, W. Fuereder,C. Piatek,M. Griffin,M. Ogawa,J. Wang,K. Usuki,A. Roeth,J. W. Lee

SWISS MEDICAL WEEKLY（2021）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn